Effect of Body Mass Index (BMI) on Tumor Characteristics and Disease-Free Survival in Patients from the HER2-Positive Adjuvant Trastuzumab Trial N9831

BACKGROUND: Data suggest that weight, and specifically BMI, plays a role in breast cancer development and outcome. We hypothesized there would be a correlation between BMI and clinical outcome in patients with early stage HER2-positive breast cancer enrolled in the N9831 adjuvant trial. METHODS: Pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Crozier, Jennifer A., Moreno-Aspitia, Alvaro, Ballman, Karla V., Dueck, Amylou C., Pockaj, Barbara A., Perez, Edith A.
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3686994/
https://ncbi.nlm.nih.gov/pubmed/23585192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28051
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items